Non classé

Primary and Updated Analyses for DESTINY-Gastric02 Study: Trastuzumab Deruxtecan Continues to Demonstrate Benefit in Metastatic Gastric and Gastro-oesophageal Cancer

Human Epidermal Growth receptor 2 (HER2) is a protein involved in normal cell growth, found in small amounts in almost all human cells, including s...

Read

RWE Research in mCRC

In a recent article published in the Future Oncology, Patient Advocates and DiCE CEO Zorana Maravic explored and enhanced the understanding of the ...

Read

Manifesto for a Healthier Europe

DiCE, together with the EU Health Coalition, urges future EU leaders to prioritise health and life sciences. Ahead of next year’s European el...

Read

EU Commission Approval of Tibsovo® (Ivosidenib) in IDH1-mutated Cholangiocarcinoma

The European Commission approved the use of Tibsovo® (Ivosidenib) as monotherapy for the treatment of locally advanced or metastatic cholangiocarc...

Read

Collaboration with COR2ED – HCC CONNECT

DiCE is pleased to collaborate with HCC CONNECT. HCC CONNECT is an international group of experts in hepatocellular carcinoma (HCC).

...

Read

Updates in Oesophageal and Gastric Cancer Research, Summer 2023

Results from the phase III ATTRACTION-5 (NCT03006705) study showed that adding nivolumab to adjuvant chemotherapy does not improve relapse-free sur...

Read

Liver Cancer Index – Data Gaps 

DiCE has started disseminating a survey this spring among clinicians, public health experts, and patient advocates to help to sketch the landscape ...

Read

Shaping Priorities for the EU4Health Funding Programme

The Commission conducted in May a targeted consultation on the EU4Health programme’s future priorities, orientation, and needs. DiCE contribu...

Read

Croatian National Policy Event on Digestive Cancers

As part of DiCE’s campaign for improving health policies in treating digestive cancers, Croatian Member, Iget will organise a hybrid National...

Read

SURVEY: Assessing AI Awareness & Perceptions Among Patient Organisations

European Patient’s Forum (EPF) is collecting responses to a survey addressed to patients’ organisations or individuals carrying out pat...

Read

In order to facilitate the use of our website, we use cookies.

Please confirm if you accept our tracking cookies. When declining the cookies, you can continue visiting the website without sending data to third party services. Read our complete cookie statement here.